Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Study of Two Doses of Botulinum Toxin A in Post-Traumatic Trigeminal Neuropathic Pain
TCTR20210811001Phase 3Recruiting
- Sponsor
- Neuroscience Research and Development Group
- Start
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in trigeminal neuralgia (TN), sponsored by Neuroscience Research and Development Group. Started Mar 2021; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on TCTR20210811001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210811001.